Live Breaking News & Updates on சாண்டர் வேன் டெவெண்டேர்

Stay updated with breaking news from சாண்டர் வேன் டெவெண்டேர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Forbion invests USD 2.3M in seed financing of CoviCept Therapeutics, Inc.


Posted on
7468
Forbion, a leading European life sciences venture capital firm, today announces a $2.3m seed investment in newly formed CoviCept Therapeutics, Inc. (“CoviCept”), a California-based company that is developing a small molecule that inhibits the replication of SARS-CoV-2 (COVID-19) and other RNA viruses.
CoviCept’s lead molecule has a unique mechanism of action that is based on interference of a host cell protein and is therefore expected to have a low risk of viral resistance. It has been demonstrated to inhibit SARS-CoV-2 replication in a relevant mammalian model at a clinically relevant dose. A manufacturing process for the lead compound has been established and it has demonstrated good bioavailability and safety in humans in phase 1 studies. ....

United States , San Diego , University Of California San Diego , Philip Gordts , Jeffrey Esko , Sander Van Deventer Forbion , Sam Tsimikas , Sander Van Deventer , European Recovery Programme , Covicept Therapeutics Inc , Dutch Venture Initiative , Covicept Therapeutics , California San , Chief Executive Officer , Operating Partner , United Nations Principles , Kfw Capital , Venture Capital Fonds , Cept Therapeutics , ஒன்றுபட்டது மாநிலங்களில் , சான் டியாகோ , பல்கலைக்கழகம் ஆஃப் கலிஃபோர்னியா சான் டியாகோ , ஜெஃப்ரி எஸ்கோ , சாண்டர் வேன் டெவெண்டேர் , ஐரோப்பிய மீட்பு ப்ரோக்ராம் , டச்சு துணிகர முயற்சி ,